{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:06:02Z","timestamp":1789513562551,"version":"build-2803163510"},"reference-count":36,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Children with sickle cell disease (SCD) are at increased risk for bloodstream infections (BSIs), mainly because of functional asplenia. Immunizations and antibiotic prophylaxis have reduced the prevalence of invasive bacterial infections, but contemporary analysis of BSI in children with SCD is limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of children aged &amp;lt;18 years with SCD who had blood cultures collected at our institution from 2010 to 2019 to identify BSI. Probable contaminant organisms were identified and not included as BSI. We calculated the annual incidence of BSI at our institution with 95% confidence intervals (CIs) and used multivariate logistic regression to evaluate associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>There were 2694 eligible patients with 19\u2009902 blood cultures. Excluding repeated cultures and contaminant cultures, there were 156 BSI episodes in 144 patients. The median age at BSI was 7.5 years. The average incidence rate of BSI was 0.89 per 100 person-years (95% CI 0.45\u20131.32). The most common pathogens were Streptococcus pneumoniae (16.0%), Streptococcus viridans group (9.0%), Escherichia coli (9.0%), Staphylococcus aureus (7.7%), Bordetella holmesii (7.7%), Haemophilus influenzae (7.1%), and Salmonella species (6.4%). Odds of BSI were higher with sickle cell anemia genotypes (odds ratio [OR] 1.88; 95% CI 1.20\u20132.94) and chronic transfusions (OR 2.66; 95% CI 1.51\u20134.69) and lower with hydroxyurea (OR 0.57; 95% CI 0.39\u20130.84).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>BSI remains a risk for children with SCD. Overall incidence, risk factors, and spectrum of pathogens are important considerations to guide prevention and empirical treatment of suspected infection in SCD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1542\/peds.2021-051892","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T03:08:39Z","timestamp":1639624119000},"source":"Crossref","is-referenced-by-count":25,"title":["Bloodstream Infections in Children With Sickle Cell Disease: 2010\u20132019"],"prefix":"10.1542","volume":"149","author":[{"given":"Marianne E.","family":"Yee","sequence":"first","affiliation":[{"name":"Aflac Cancer and Blood Disorders Center"},{"name":"Departments of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina W.","family":"Lai","sequence":"additional","affiliation":[{"name":"Aflac Cancer and Blood Disorders Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitya","family":"Bakshi","sequence":"additional","affiliation":[{"name":"Aflac Cancer and Blood Disorders Center"},{"name":"Departments of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna K.","family":"Grossman","sequence":"additional","affiliation":[{"name":"Aflac Cancer and Blood Disorders Center"},{"name":"Departments of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Jaggi","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Mallis","sequence":"additional","affiliation":[{"name":"Aflac Cancer and Blood Disorders Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun F.","family":"Wang","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine, School of Medicine"},{"name":"Department of Pathology and Laboratory Medicine, Grady Health System, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Jerris","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine, School of Medicine"},{"name":"Department of Pathology and Laboratory Medicine, Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Lane","sequence":"additional","affiliation":[{"name":"Aflac Cancer and Blood Disorders Center"},{"name":"Departments of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inci","family":"Yildirim","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics"},{"name":"Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia"},{"name":"Center for Childhood Infections and Vaccines, Emory University and Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2021,12,23]]},"reference":[{"issue":"17","key":"2022020115320274800_B1","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJM196910232811703","article-title":"Functional asplenia in sickle-cell anemia","volume":"281","author":"Pearson","year":"1969","journal-title":"N Engl J Med."},{"issue":"3","key":"2022020115320274800_B2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/pbc.22461","article-title":"Susceptibility to invasive bacterial infections in children with sickle cell disease","volume":"55","author":"Battersby","year":"2010","journal-title":"Pediatr Blood Cancer."},{"issue":"5","key":"2022020115320274800_B3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/adc.57.5.343","article-title":"Defective yeast opsonisation and functional deficiency of complement in sickle cell disease","volume":"57","author":"Larcher","year":"1982","journal-title":"Arch Dis Child."},{"issue":"1","key":"2022020115320274800_B4","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.ijid.2009.03.010","article-title":"Infection in sickle cell disease: a review","volume":"14","author":"Booth","year":"2010","journal-title":"Int J Infect Dis."},{"issue":"2","key":"2022020115320274800_B5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11239-013-0914-z","article-title":"Short-term central venous catheter complications in patients with sickle cell disease who undergo apheresis","volume":"37","author":"Yeral","year":"2014","journal-title":"J Thromb Thrombolysis."},{"issue":"6","key":"2022020115320274800_B6","doi-asserted-by":"crossref","first-page":"e27667","DOI":"10.1002\/pbc.27667","article-title":"Low-risk factors for severe bacterial infection and acute chest syndrome in children with sickle cell disease","volume":"66","author":"Rinc\u00f3n-L\u00f3pez","year":"2019","journal-title":"Pediatr Blood Cancer."},{"issue":"11","key":"2022020115320274800_B7","doi-asserted-by":"crossref","first-page":"e26635","DOI":"10.1002\/pbc.26635","article-title":"Increased complications of chronic erythrocytapheresis compared with manual exchange transfusions in children and adolescents with sickle cell disease","volume":"64","author":"Woods","year":"2017","journal-title":"Pediatr Blood Cancer."},{"issue":"5","key":"2022020115320274800_B8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MPH.0b013e31828ac9e2","article-title":"Predictors for bacteremia in febrile sickle cell disease children in the post-7-valent pneumococcal conjugate vaccine era","volume":"35","author":"Chang","year":"2013","journal-title":"J Pediatr Hematol Oncol."},{"issue":"4","key":"2022020115320274800_B9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0022-3476(86)80216-5","article-title":"Bacteremia in sickle hemoglobinopathies","volume":"109","author":"Zarkowsky","year":"1986","journal-title":"J Pediatr."},{"issue":"2","key":"2022020115320274800_B10","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1182\/blood.V86.2.776.bloodjournal862776","article-title":"Clinical events in the first decade in a cohort of infants with sickle cell disease","volume":"86","author":"Gill","year":"1995","journal-title":"Blood."},{"issue":"6","key":"2022020115320274800_B11","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1542\/peds.2012-2139","article-title":"Bacteremia risk and outpatient management of febrile patients with sickle cell disease","volume":"131","author":"Baskin","year":"2013","journal-title":"Pediatrics."},{"issue":"9698","key":"2022020115320274800_B12","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0140-6736(09)61374-X","article-title":"Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study","volume":"374","author":"Williams","year":"2009","journal-title":"Lancet."},{"issue":"4","key":"2022020115320274800_B13","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1067\/S0022-3476(03)00331-7","article-title":"Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination","volume":"143","author":"Adamkiewicz","year":"2003","journal-title":"J Pediatr."},{"issue":"3","key":"2022020115320274800_B14","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1542\/peds.2007-0018","article-title":"Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life","volume":"121","author":"Adamkiewicz","year":"2008","journal-title":"Pediatrics."},{"issue":"1","key":"2022020115320274800_B15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/MPH.0b013e318240d50d","article-title":"Bacteremia in children with sickle hemoglobinopathies","volume":"34","author":"Narang","year":"2012","journal-title":"J Pediatr Hematol Oncol."},{"issue":"25","key":"2022020115320274800_B16","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM198606193142501","article-title":"Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial","volume":"314","author":"Gaston","year":"1986","journal-title":"N Engl J Med."},{"issue":"6","key":"2022020115320274800_B17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jinf.2012.08.005","article-title":"Invasive Haemophilus influenzae in the United States, 1999-2008: epidemiology and outcomes","volume":"65","author":"Livorsi","year":"2012","journal-title":"J Infect."},{"key":"2022020115320274800_B18","first-page":"255","article-title":"Pneumococcal disease","volume-title":"Epidemiology and Prevention of Vaccine-Preventable Diseases.","author":"Centers for Disease Control and Prevention","year":"2015","edition":"13th ed."},{"issue":"9","key":"2022020115320274800_B19","first-page":"253","article-title":"Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"3","key":"2022020115320274800_B20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jpeds.2010.11.025","article-title":"Increase in invasive Streptococcus pneumoniae infections in children with sickle cell disease since pneumococcal conjugate vaccine licensure","volume":"158","author":"McCavit","year":"2011","journal-title":"J Pediatr."},{"issue":"4","key":"2022020115320274800_B21","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/bjh.15846","article-title":"Risk of invasive pneumococcal disease in children with sickle cell disease in the era of conjugate vaccines: a systematic review of the literature","volume":"185","author":"Oligbu","year":"2019","journal-title":"Br J Haematol."},{"issue":"3","key":"2022020115320274800_B22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1542\/peds.2014-2426","article-title":"Vaccination, underlying comorbidities, and risk of invasive pneumococcal disease","volume":"135","author":"Yildirim","year":"2015","journal-title":"Pediatrics."},{"issue":"6","key":"2022020115320274800_B23","doi-asserted-by":"crossref","first-page":"e27642","DOI":"10.1002\/pbc.27642","article-title":"Incidence of invasive Haemophilus influenzae infections in children with sickle cell disease","volume":"66","author":"Yee","year":"2019","journal-title":"Pediatr Blood Cancer."},{"issue":"3","key":"2022020115320274800_B24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/pbc.22605","article-title":"Prevalence of daily medication adherence among children with sickle cell disease: a 1-year retrospective cohort analysis","volume":"55","author":"Patel","year":"2010","journal-title":"Pediatr Blood Cancer."},{"issue":"3","key":"2022020115320274800_B25","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/archpediatrics.2009.286","article-title":"Adherence to prophylactic antibiotic guidelines among Medicaid infants with sickle cell disease","volume":"164","author":"Warren","year":"2010","journal-title":"Arch Pediatr Adolesc Med."},{"key":"2022020115320274800_B26","volume-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically.","author":"Clinical and Laboratory Standards Institute","year":"2018","edition":"11th ed."},{"key":"2022020115320274800_B27","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing.","author":"Clinical and Laboratory Standards Institute","year":"2020","edition":"30th ed."},{"issue":"4","key":"2022020115320274800_B28","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1128\/CMR.00062-05","article-title":"Updated review of blood culture contamination","volume":"19","author":"Hall","year":"2006","journal-title":"Clin Microbiol Rev."},{"key":"2022020115320274800_B29","unstructured":"Centers for Disease Control and Prevention, Division of Preparedness and Emerging Infections (DPEI)\n          . Emerging infections program. 2018. Available at: https:\/\/www.cdc.gov\/ncezid\/dpei\/eip\/index.html. Accessed August 31, 2021"},{"key":"2022020115320274800_B30","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement.","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"2022020115320274800_B31","unstructured":"National Heart, Lung, and Blood Institute\n          . Cooperative Study of Sickle Cell Disease (CSSCD). 2008. Available at: https:\/\/biolincc.nhlbi.nih.gov\/studies\/csscd\/. Accessed June 15, 2021"},{"issue":"6","key":"2022020115320274800_B32","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1086\/381888","article-title":"Bordetella holmesii bacteremia: a newly recognized clinical entity among asplenic patients","volume":"38","author":"Shepard","year":"2004","journal-title":"Clin Infect Dis."},{"key":"2022020115320274800_B33","volume-title":"Evidence-Based Management of Sickle Cell Disease: Expert Panel Report, 2014.","author":"National Heart, Lung, and Blood Institute","year":"2014"},{"issue":"4","key":"2022020115320274800_B34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/01.RVI.0000121410.46920.6E","article-title":"Infectious complications of implantable venous access devices in patients with sickle cell disease","volume":"15","author":"Wagner","year":"2004","journal-title":"J Vasc Interv Radiol."},{"issue":"1","key":"2022020115320274800_B35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jiph.2011.10.004","article-title":"Complications of PORT-A-CATH\u00ae in patients with sickle cell disease","volume":"5","author":"Alkindi","year":"2012","journal-title":"J Infect Public Health."},{"issue":"2","key":"2022020115320274800_B36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ajh.10047","article-title":"Central venous catheter complications in sickle cell disease","volume":"69","author":"Jeng","year":"2002","journal-title":"Am J Hematol."}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-051892\/1255844\/peds_2021051892.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-051892\/1255844\/peds_2021051892.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T10:32:44Z","timestamp":1643711564000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/149\/1\/e2021051892\/183842\/Bloodstream-Infections-in-Children-With-Sickle"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,23]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,23]]},"published-print":{"date-parts":[[2022,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2021-051892","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,23]]},"article-number":"e2021051892"}}